184 participants
Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2019-04-30
- Start Date:
- 2019-06-24
- Completion:
- 2022-12-12
Conditions
- Triple-negative Breast Cancer
Interventions
- DRUG
No Results Yet